Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705925 · ClinicalTrials.gov registry record
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 92
- Enrollment target
NCT01705925: Completed study, sponsored by Pediatrix.
NCT01705925 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01705925 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
The purpose of the study is to provide comprehensive follow-up in patients with Long QT Syndrome (LQTS) and gain additional information regarding genotype-phenotype correlation and effective management and treatment options.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2012-03 |
| Est. Completion | 2018-12 |
What the finished NCT01705925 record still lists
NCT01705925 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01705925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01705925 about?
NCT01705925 is a clinical study titled "Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome". The purpose of the study is to provide comprehensive follow-up in patients with Long QT Syndrome (LQTS) and gain additional information regarding genotype-phenotype correlation and effective management and treatment options.
What is the current status of trial NCT01705925?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2012-03. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01705925?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia